2020
DOI: 10.1016/j.ctim.2019.102273
|View full text |Cite
|
Sign up to set email alerts
|

The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 45 publications
5
12
0
Order By: Relevance
“…However, the serum lipids, including triglycerides, total cholesterol, and low-density lipoproteins LDL cholesterol, were reported to remain unchanged with L-carnitine supplementation in other studies [ 70 , 71 ]. Contradicted results on lipid parameters of various human diseases upon L-carnitine supplementation have also been reported, suggesting underlying conditions that can complicate the interpretation [ 72 ].…”
Section: Resultsmentioning
confidence: 99%
“…However, the serum lipids, including triglycerides, total cholesterol, and low-density lipoproteins LDL cholesterol, were reported to remain unchanged with L-carnitine supplementation in other studies [ 70 , 71 ]. Contradicted results on lipid parameters of various human diseases upon L-carnitine supplementation have also been reported, suggesting underlying conditions that can complicate the interpretation [ 72 ].…”
Section: Resultsmentioning
confidence: 99%
“…L-carnitine, the only biologically active form of carnitine, has been one of the most widely studied molecules for the treatment of NAFLD. Several meta-analyses showed that L-carnitine supplementation improved steatosis and NASH ( 67 ) and carnitine supplementation in NAFLD patients could reduce AST, ALT, TG, and HOMA-IR ( 95 ). In yet another meta-analysis, L-carnitine supplementation was found to significantly improve the circulating levels of ALT, AST, and gamma-glutamyl transpeptidase (γ-GT), which may have a positive impact on liver function ( 96 ).…”
Section: Treatment Of Nafld With L-carnitine Supplementationmentioning
confidence: 99%
“…In addition, several works have reported that LC ameliorates NAFLD condition decreases lipid accumulation and prevents NAFLD-induced heart dysfunction. The possible mechanism of this LC action is related to its ability to activate redox-signaling pathways, promoting mitochondrial activities and AMPK signaling [200,201]. In confirmation of the AMPK role in LC action, our group recently demonstrated that LC supplementation mitigates liver steatosis induced by fructose, activating AMPK and consequently increasing anti-oxidative cellular response [202].…”
Section: From Caloric Restriction To Cr-related Nutrients: L-carnitinementioning
confidence: 90%